异位妊娠时子宫内膜的形态变化

目的：探讨异位妊娠时子宫内膜形态变化的规律。方法：回顾分析我院２１７例异位妊娠子宫内膜的形态变化。结果：异位妊娠时子宫内膜变化有７种类型：（１）蜕膜和Ａｒｉａｓ－Ｓｔｅｌａ反应（Ａ－Ｓ反应）；（２）高度分泌反应；（３）分泌反应不同步；（４）部分呈分泌反应、部分呈增生反应，并出现一种“小Ａ－Ｓ”腺体；（５）早、中、晚分泌期；（６）增生反应；（７）腺囊型增生过长。异位妊娠时内膜形态与有无阴道流血、流血时间长短及尿ｈＣＧ水平有关。结论：不能以是否出现蜕膜和Ａ－Ｓ反应做为诊断异位妊娠的依据，须结合病史和实验室检查才能准确判断。     

Direct gamete uterine transfer in patients with tubal absence or occlusion

Purpose: Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. Design: A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Methods: Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram-and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration. Results: Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation. Conclusions: Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.     

肿瘤坏死因子在妊高征发病中的作用

目的：探讨肿瘤坏死因子（ＴＮＦ）在妊高征发病中的作用及其对胎儿生长的影响。方法：应用放射免疫法对正常晚期妊娠妇女１６例（对照组）及妊高征患者４６例（妊高征组）的血浆、羊水和新生儿脐血中ＴＮＦ进行检测。结果：分娩前妊高征组血浆ＴＮＦ水平较对照组高，以中、重度妊高征者增高显著（Ｐ＜０．０５）；产后７２小时妊高征组血浆ＴＮＦ水平下降，与对照组差异无显著性。对照组及轻度妊高征者新生儿脐血ＴＮＦ水平与母血接近，羊水ＴＮＦ水平明显低于母血（Ｐ＜０．０５）；中、重度妊高征者脐血和羊水ＴＮＦ水平均较母血低（Ｐ＜０．０５；Ｐ＜０．０１）。新生儿脐血、羊水中ＴＮＦ水平在两组间差异无显著性。在中、重度妊高征者中，合并胎儿生长迟缓者其羊水和新生儿脐血ＴＮＦ水平明显高于未合并胎儿生长迟缓者。结论：ＴＮＦ可能作为母体对胎儿抗原的异常免疫反应的重要介质，在妊高征的发病中起一定作用。     

肿瘤坏死因子对妊高征的致病作用及与内皮素的关系

目的：探讨肿瘤坏死因子在妊高征发病中的作用及与内皮素的关系。方法：采用放射免疫法测定了４６例妊高征患者（妊高征组）和２０例正常晚期妊娠妇女（对照组）血浆肿瘤坏死因子（ＴＮＦ）和内皮素（ＥＴ－１）的质量浓度。结果，妊高征组中，重度患者ＴＮＦ和ＥＴ－１质量浓度明显高于对照且和轻度患者（Ｐ〈０．０５及Ｐ〈０．０１）；产后７２小时两者质量浓度均明显下降。对照组血浆ＴＮＦ与ＥＴ－１质量浓度无相关性，而妊高征     

孕妇下生殖道解脲脲原体感染与妊娠结局关系的探讨

应用聚合酶链反应技术，对２１６例妊娠１２－３７周孕妇的宫颈阴道分泌物和其中１０９例有孕妇分娩时的羊水进行解脲脲原体ＤＮＡ检测，同时临床观察２１６例孕妇的妊娠结局。结果：宫颈阴道分泌物ＵＵ ＤＮＡ阳性率为４３．０６％，宫颈阴道ＵＵ ＤＮＡ阳性组对应的羊水ＵＵ检出率明显高于阴性组，两组平均孕周，平均出生体重，平均Ａｐｇａｒ评分以及胎儿窘迫，早产，剖宫产，低出生体重儿，低Ａｐｇａｒ评分和瘭生儿畸形的发五     

妊娠高血压综合征孕妇血浆一氧化氮和内皮素的变化及其意义

目的：探讨一氧化氮（ＮＯ）和内皮素（Ｅｎｄｏｔｈｅｌｉｎ，ＥＴ）在妊高征发病中的变化及其病理意义。方法：用分光光度法和放射免疫法分别定量检测正常妊娠３０例（对照组）和妊高征３７例（妊高征组）血浆ＮＯ和ＥＴ的变化。结果：妊高征组血浆ＮＯ水平低于对照组（Ｐ＜０．０１），ＥＴ水平则高于对照组（Ｐ＜０．０１）；妊高征组分娩前后相比，ＮＯ水平分娩后升高（Ｐ＜０．０１），ＥＴ水平则下降（Ｐ＜０．０１），ＮＯ、ＥＴ呈显著负相关（Ｐ＜０．０１），ＮＯ、ＥＴ与平均动脉压均有显著相关性（Ｐ＜０．０１）。结论：ＮＯ与ＥＴ在妊高征的发病机制中有重要作用，ＥＴ／ＮＯ失衡可以反映妊高征的病变程度，其病理变化在某种程度上呈可逆性。     

妊高征患者的胎儿血流速度波形改变特点研究

目的：研究妊高征患者的胎儿脐动脉、肾动脉以及大脑中动脉的血流速度波形的变化特点。方法：妊高征患者９６例，正常妊娠１４８例，于产前１周内行彩色多普勒超声检测胎儿脐动脉、肾动脉和大脑中动脉的搏动指数（ＰＩ），产后随访新生儿预后。结果：随着妊高征的加剧，胎儿脐动脉和肾动脉的ＰＩ上升，大脑中动脉的ＰＩ则改变不明显。在围产儿预后良好和不良的两组中，随着妊高征的加重，胎儿脐动脉、肾动脉和大脑中动脉的ＰＩ均有上升的趋势，但预后不良组的改变比对照组明显。按正常妊娠和轻度、中度、重度妊高征分成４组，胎儿窘迫者脐动脉和肾动脉的ＰＩ上升，大脑中动脉的ＰＩ下降。结论：妊高征和胎儿窘迫对胎儿脐动脉和肾动脉的血流波形改变有协同作用，对大脑中动脉的改变有阻抗作用     

妊高征患者合体滋养细胞质膜部分生化指标的变化

目的：研究妊高征（ＰＩＨＳ）患者胎盘合体滋养细胞质膜（ＳＴＣＰＭ）中生化指标的变化及原因。方法：ＰＩＨＳ２４例，其中轻度８例、中度７例、重度９例，以正常孕妇１８例作对照，用Ｗｈｉｔｓｅｔ等法制备ＳＴＣＰＭ，以孔雀石绿无机磷法（ＭＧＩｏＰＡ）测定ＡＴＰａｓｅ的活性，用ＤＰＨ荧光探针测定膜的微粘度来推断膜的流动性，用硫代巴比妥酸荧光微量测定法测丙二醛酸（ＭＤＡ）以代表脂质过氧化物（ＬＰＯ）。结果：ＰＩＨＳ组Ｎａ＋、Ｋ＋－ＡＴＰａｓｅ、Ｃａ２＋、Ｍｇ２＋－ＡＴＰａｓｅ活性均显著低于对照组（Ｐ＜０．０５），且随病情加重而降低，膜的流动性亦显著降低（Ｐ＜０．０５），ＭＤＡ则显著增高，且随病情加重而增高；ＭＤＡ与两种ＡＴＰ酸呈负相关关系（Ｐ＜０．０５）。结论：ＰＩＨＳ的ＳＴＣＰＭ生化指标发生变化，其变化的原因之一是脂质过氧化作用增强     

67例梅毒临床分析

对１９９６年３月１日～１９９７年９月３０日诊治的６７例梅毒进行临床分析。结果：６７例均为早期梅毒，其中妊娠期梅毒２４例，隐性梅毒１３例，３０岁以下患者占７６．１２％。提示年轻梅毒患者有增加趋势，通过胎盘血行传播危险性大，对第一次接受产前检查的孕妇应常规进行梅毒筛查，隐性梅毒发病率较高，故对所有可疑病例应常规做梅毒筛查。     

Does Previous Salpingectomy Improve Implantation and Pregnancy Rates in Patients with Severe Tubal Factor Infertility who are Undergoing In Vitro Fertilization? A Pilot Prospective Randomized Study

Objective: To evaluate the implantation rate and pregnancy rate (PR) in patients with severe tubal factor infertility who were undergoing IVF. Patients who had undergone salpingectomy were compared with those who had not.

Design: A prospective randomized study.

Setting: A department of obstetrics and gynecology at a university hospital.

Patient(s): Thirty patients who previously had undergone salpingectomy and 30 patients who had not undergone salpingectomy before IVF treatment.

Intervention(s): Laparoscopy with or without salpingectomy followed by IVF with the use of combined GnRH agonist and hMG therapy in a long stimulation protocol.

Main Outcome Measure(s): Embryo implantation rate and ongoing PR per transfer. The cumulative PRs were compared for the two groups of patients.

Result(s): After the first IVF attempt, the implantation rate was 10.4% in the group with salpingectomy and 4.6% in the group without salpingectomy. For all IVF attempts, the respective embryo implantation rates in the two groups were 13.4% and 8.6%. The ongoing PR per transfer was 34.2% in the group with salpingectomy compared with 18.7% in the group without salpingectomy. After four IVF attempts, the probability of becoming pregnant was greater in the group of patients with salpingectomy (75%) than in the group without salpingectomy (63%).

Conclusion(s): Previous salpingectomy in patients with severe tubal factor infertility who are undergoing IVF seems to increase the embryo implantation rate and the PR per cycle of IVF. This monocentric study must be followed by other similar studies to allow for a metaanalysis and confirm this clear trend with definitive evidence.